key: cord-0818438-070s1xq7 authors: Kamal, Mona; Baudo, Massimo; Shmushkevich, Shon; Geng, Yimin; Hanna, Ehab; Goepfert, Ryan P.; Lewis, Carol M.; Rahouma, Mohamed title: COVID‐19 infection and its consequences among surgical oncology patients: A systematic analysis, meta‐analysis and meta‐regression date: 2022-01-11 journal: J Surg Oncol DOI: 10.1002/jso.26787 sha: 4191f3bfa0689522e27c6387a97c56bc04e231cc doc_id: 818438 cord_uid: 070s1xq7 We conducted this meta‐analysis to address the outcomes in cancer patients after oncologic surgery during COVID‐19 pandemic. The primary endpoint was the COVID‐19–related mortality rate. Higher body mass index was significantly and negatively associated with higher all‐cause mortality and in‐hospital COVID‐19 infection rates. Male sex, preoperative respiratory disease, and smoking history were positively and significantly associated with increased all‐cause mortality rates. Furthermore, male sex was positively and significantly associated with the COVID‐19 infection rate. cannot be modified to determine the patient's readiness for oncologic surgery. 8 Additional factors must be considered during the COVID-19 pandemic: uncertain COVID-19 infection trajectory, actual infection risk among health care providers, and expected vaccine protection rates. 3, 9 Moreover, some surgical procedures may require interventional radiologic or endoscopic procedures and/or admission to an intensive care unit (ICU) postoperatively or emergency room (ER) perioperatively. Furthermore, virtual perioperative appointments, limited numbers of caregivers and visitors, and additional barriers designed to protect patients and health care providers from infection may further complicate interventions and patient advocacy. 2, 10, 11 The available published data on, international recommendations for, and global experience with infections in cancer patients may help overcome the challenges described above. 2, [12] [13] [14] Nevertheless, our understanding of the COVID-19 pandemic is evolving, and the oncologic surgery workflow must be revisited, updated, and optimized as a result to account for the range of institutional, local, and national conditions during the pandemic. Therefore in this systematic review, meta-analysis, and meta-regression, we analyzed the measurable reported outcomes and identified potential predictors of poor outcome in cancer patients who had oncologic surgery during the COVID-19 pandemic. A systematic review and meta-analysis were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. 15 The Ovid MEDLINE, Ovid Embase, Clarivate Analytics Web of Science, PubMed, and Wiley-Blackwell Cochrane Library databases were searched for articles published in English from December 1, 2019, to September 21, 2020. The databases were searched for the following terms: COVID-19, severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, coronavirus infections, novel coronavirus, cancer, neoplasms, tumor, leukemia, lymphoma, melanoma, carcinoma, sarcoma, oncology, surgery, surgical, neurosurgery, resection, perioperative care, perioperative period, and postoperative complications. The search terms were combined with "or" if they represented similar concepts and with "and" if they represented different concepts. The complete search strategies are detailed in Tables S1-S4. Comparative studies eligible for this systematic review and metaanalysis consisted of those with reported outcomes of patients who were scheduled for oncologic surgery during the COVID-19 pandemic. Studies with fewer than five patients were excluded. For duplicate published studies from the same institution, only the most complete reports were included. In addition, the bibliographies of all studies and meta-analyses were searched to identify additional articles (i.e., backward snowballing). Abstracts, conference presentations, reviews, and expert opinions were excluded. Excel software (Microsoft Corporation) was used for extraction of data from the studies we identified. Continuous variables were reported as mean (±SD) values, and categorical variables were expressed as frequencies. Data on study period, study center, country, type of cancer, type of study, and sample size were retrieved. The following patient characteristics were abstracted: age, male sex, body mass index (BMI), diabetes, renal insufficiency, coronary artery disease, acute kidney injury, peripheral artery disease, smoking history, pre-existing pulmonary disease, and dyslipidemia. Of note, smoking history data were not consistent across studies. Some authors reported this variable as "history of smoking," whereas other authors added more details, such as "former" versus "current" smoker. Comorbidities (e.g., pre-existing pulmonary disease, dyslipidemia), smoking history, BMI, and sex were examined as separate variables, although the possible collinearity could not be assessed or ignored. The primary endpoint was the COVID-19-related mortality rate, which was calculated for the entire patient population. The secondary endpoints were length of hospital stay and the rates of in-hospital For the short-term categorical and continuous outcomes, pooled event rates (PERs) and pooled means with their 95% confidence intervals (CIs) were calculated using the DerSimonian-Laird (inverse variance) method. Subgroup analysis was conducted to evaluate the primary endpoint according to the type of cancer. Univariable meta-regression was performed to explore the relationship of the endpoints with preoperative characteristics. Each study was weighted according to the inverse of the variance of the estimate of that study, and between-study variance was estimated using a DerSimonian-Laird estimator. The meta-regression results were reported using regression coefficients (i.e., β), SEs, and p values. Hypothesis testing for equivalence was two-tailed with a 0.05 significance level except for the subgroup analysis. A significance level of 0.06 was adopted. Heterogeneity assessment was performed based on the Cochran Q test with I 2 values. Individual study inference analysis was performed via leave-one-out sensitivity analysis for the primary endpoint. Funnel plots by graphical inspection and Egger regression testing were used for assessment of publication bias regarding the primary endpoint. All statistical analyses were performed using the R computing language (version 3.6.2) and RStudio software with the meta and metafor packages. We identified a total of 1936 studies in our database search. After exclusion of duplicates and irrelevant articles, we screened 1026 potentially relevant articles. We then assessed 72 full-text articles for eligibility. Twenty-eight studies with a total of 3508 patients met our inclusion criteria. The sample sizes ranged from 5 to 621. An outline of the systematic review process performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines is shown in Figure S1 . The characteristics and demographics of the patients in the included studies are summarized in Table 1 and Table S5 . We used the Newcastle-Ottawa Quality Assessment Scale for cohort studies to critically appraise the quality of the included studies (Table S6) . 16 3.2 | Meta-analysis of the outcomes The PER for in-hospital COVID-19 infection was 3.00% (95% CI: 1.88%-4.73%) ( Figure S2 ). The PER for all-cause mortality was 2.68% (95% CI: 1.23%-5.72%) ( Figure 3A ), and that for surgery postponement because of COVID-19 infection was 2.80% (95% CI: 1.49%-5.18%) ( Figure 3B ). The PER for overall COVID infection was 3.49% (95% CI: 2.34%-5.17%) ( Figure S3 ). The PER for length of hospital stay was 7.26 days (95% CI: 5.03-10.48 days) ( Figure S4 ). The PER for hospital readmission was 2.74% (95% CI: 1.93%-3.88%) ( Figure S5 ). The PER for postoperative complications was 11.44% (95% CI: 7.30%-17.48%) ( Figure S6 ). The PER for ER visits was 2.18% (95% CI: 0.38%-11.51%) ( Figure S7 ). The PER for surgical recovery was 92.03% (95% CI: 73.86%-97.92%) ( Figure S8 ). The PER for COVID-19 infection recovery was 72.85% (95% CI: 61.84%-81.62%) ( Figure S9 ). The PER for ICU admission was 3.82% (95% CI: 1.28%-10.87%) ( Figure S10 ). The PER for need for a ventilator was 9.85% (95% CI: 1.98%-37.20%) ( Figure S11 ). The PER for pulmonary complications was 5.96% (95% CI: 3.24%-10.71%) ( Figure S12 ). The patient outcomes are summarized in Table 2 . Subgroup analysis of the primary endpoint showed a nonsignificant trend of higher COVID-19-related mortality rates in patients with thoracic or lung cancer than in those with other cancers (subgroup difference, p = 0.30) ( Figure S13 ). BMI was significantly and negatively associated with all-cause mortality (p < 0.001) and in-hospital COVID-19 infection (p = 0.0064) rates. Also, male sex was positively and significantly associated with the COVID-19 infection rate (p = 0.0479) and an increased all-cause mortality rate (p < 0.001). Finally, preoperative respiratory disease (p = 0.0079) and smoking history (p = 0.0151) were positively and significantly associated with an increased all-cause mortality rate. Meta-regression outcomes are summarized in Table 3 . In these cohorts of cancer patients scheduled for oncologic surgery during the COVID-19 era, the calculated early mortality rate after COVID-19 infection was 27%. This aligns with published data demonstrating that the mortality rate may reach 20% in general surgical patients 17 and even higher (25%) in cancer patients who undergo surgical intervention. 18 The investigators in the latter study reported that the high mortality rate was attributed to COVID-19 infection in the patients. 18 Over time, the mortality rate during the COVID-19 pandemic has improved, likely due to improved understanding of the infection trajectory and implementation of more optimal care algorithms. 18 Furthermore, we report herein the PER for all-cause mortality which was 2.68%. These rates are similar to the COVID-19 mortality rate of 3.6% that was reported by Rajasekaran et al. 19 Therefore, authors have suggested following international guidelines and implementing recommended adjustments to the surgical workflow for the purpose of overcoming the pandemic-related restrictions on the workflow. 27 We agree that safety should come first, so surgical scheduling may have to be adjusted according to the national situation and medical resources. Still, maintenance of safety should not compromise patient outcomes. We must also remember that cancer patients require special considerations and extra measures. 28 In our meta-analysis, the PER for postoperative complications was 11%. Authors reported a postoperative complication rate of 12% in patients with gynecologic cancer, 23 and Lisa et al. 29 reported a lack of a significant difference in the complication rate after breast reconstruction before and after the start of the COVID-19 pandemic. Our analysis also showed that BMI is negatively associated with all-cause mortality and COVID-19 infection rates in cancer patients. This aligns with published data demonstrating that higher BMI or obesity contributes to higher morbidity and mortality rates after COVID-19 infection. [31] [32] [33] [34] [35] The detrimental effect of obesity after COVID-19 infection may be attributed to the observed negative effects of obesity of impaired immune function and decreased lung capacity and reserve. 31, [34] [35] [36] Smoking is another major risk factor for poor oncologic sur- Investigators have observed that delaying or canceling surgery for cancer may impact mortality, as well. Also, as we acknowledged earlier, cancer patient characteristics overlap (sex, BMI, comorbidities, smoking history, and even age). We collected and analyzed each of these variables separately, but the overlap of these factors is impossible to ignore and assess. Furthermore, we sought to present as much valuable data as possible, but we were challenged by the heterogeneous definitions of some outcomes in the studies (i.e., recovery rates). Also, a point to consider is the possible impact of missing data on the patients who underwent treatment outside a hospital or were lost to follow-up, especially when it comes to the impact of missing data on recovery rates. During the first wave of the COVID-19 pandemic, the rate of oncologic surgical procedures decreased by 80%. 8 Furthermore, authors reported that 44% of cancer patients needed ICU admission. 17 These rates have improved greatly since that time. Balancing the competing requirements of safety, timely oncologic care, and optimal use of operation units, ERs, and ICUs is always essential before setting workflows for oncologic surgical care. 2, 4, 9, 11, 12, 14 We must face the reality that the COVID-19 pandemic may be prolonged, as we are still learning about the course of the disease, and not everyone has access to and/or received the vaccine. Moreover, new strains are emerging, and the vaccine does not provide 100% protection. Data demonstrate that cancer does not appear to be associated with an elevated risk of COVID-19 infection as long as preventive measures are taken for selected patients. 52 However, COVID-19 infection is always a risk for cancer patients during preparation for surgery. Therefore, we extensively reviewed published data to guide effective clinical care for cancer patients who need surgical interventions. As the rates of COVID-19 infection decline and access to vaccines expands, our hope is that this progress enables full oncologic surgical capacity while maintaining the safety of patients and providers and prioritization of the oncologic surgical workflow based on institutional resources and the national situation. 53, 54 Our data reported herein constitute a reliable, solid resource to help oncologic surgeons better understand the trajectory and outcomes of COVID-19 infection and identify cancer patients at increased risk for poor surgical outcomes. Management of cancer surgery cases during the COVID-19 pandemic: considerations Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: a multidisciplinary approach Approaching surgical triage during the COVID-19 pandemic Effect of preoperative counseling on hospital length of stay and readmissions after total laryngectomy. Otolaryngol Head Neck Surg Preoperative patient preparation in enhanced recovery pathways Pre-operative counselling for laryngectomy patients: a systematic review Cancer surgery scheduling during and after the COVID-19 first wave: The MD Anderson Cancer Center Experience Personal protective equipment and COVID-19: a review for surgeons A combined approach to priorities of surgical oncology during the COVID-19 epidemic Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China Safety recommendations for evaluation and surgery of the head and neck during the COVID-19 pandemic Gynaecologic cancer care during COVID-19 pandemic in India: a social media survey Surgical prehabilitation in patients with cancer: state-of-the-science and recommendations for future research from a panel of subject matter experts The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies Patient safety associated with the surgical treatment of bone and soft tissue tumours during the COVID-19 pandemic-results from an observational study at the Oxford Sarcoma Service Outcomes of elective head and neck confirmed or suspected cancer surgery during the COVID-19 pandemic The challenge of COVID-19: the biological characteristics and outcomes in a series of 130 breast cancer patients operated on during the pandemic Cancer patients affected by COVID-19: experience from Milan Performing gynecologic cancer surgery during the COVID-19 pandemic in Turkey: a multicenter retrospective observational study Is elective cancer surgery safe during the COVID-19 pandemic? Covid-19: all non-urgent elective surgery is suspended for at least three months in England Impact of delay to surgery on survival in stage I-III colon cancer Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an international collaborative group Breast reconstruction in a coronavirus disease Effect of the COVID-19 pandemic on surgical breast cancer care in the netherlands: a multicenter retrospective cohort study High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation More severe obesity leads to more severe COVID-19 in study Obesity and COVID-19: what makes obese host so vulnerable? T lymphopaenia in relation to body mass index and TNF-alpha in human obesity: adequate weight reduction can be corrective Changes in nutritional status impact immune cell metabolism and function Global pandemics interconnected-obesity, impaired metabolic health and COVID-19 Sex difference and smoking predisposition in patients with COVID-19 COVID-19 and smoking: a systematic review of the evidence Association of smoking and cumulative pack-year exposure with COVID-19 outcomes in the cleveland clinic COVID-19 registry Cigarette smoking and COVID-19: a complex interaction Preexisting respiratory diseases and clinical outcomes in COVID-19: a multihospital cohort study on predominantly African American population Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis Clinical characteristics of and outcomes for patients with COVID-19 and comorbid lung diseases primarily hospitalized in a conventional pulmonology unit: a retrospective study Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China Clinical Characteristics and Outcomes of 74 Patients With Severe or Critical COVID-19 Cancer care in a Western Indian tertiary center during the pandemic: surgeon's perspective How essential is to focus on physician's health and burnout in coronavirus (COVID-19) pandemic? Cureus Expectations, fears and perceptions of doctors during Covid-19 pandemic The impact of the COVID-19 pandemic on suicide rates Breast cancer surgery during the COVID-19 pandemic peak in the UK: operative outcomes Plastic surgery and the COVID-19 pandemic: a review of clinical guidelines Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study The authors appreciate the support from the Research Medical Library at The University of Texas MD Anderson Cancer Center, especially the great help from Donald Norwood for editing the draft. Funding information is not available. The authors declare that there are no conflict of interests. Not available. https://orcid.org/0000-0003-1626-2657 Additional supporting information may be found in the online version of the article at the publisher's website.